Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model.
Lau SP, van Montfoort N, Kinderman P, Lukkes M, Klaase L, van Nimwegen M, van Gulijk M, Dumas J, Mustafa DAM, Lievense SLA, Groeneveldt C, Stadhouders R, Li Y, Stubbs A, Marijt KA, Vroman H, van der Burg SH, Aerts J, van Hall T, Dammeijer F, van Eijck CHJ.
Lau SP, et al. Among authors: dumas j.
J Immunother Cancer. 2020 Jul;8(2):e000772. doi: 10.1136/jitc-2020-000772.
J Immunother Cancer. 2020.
PMID: 32690771
Free PMC article.